PRODUCT LITERATURE
Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial
Migrainous vertigo is a common cause of dizziness presenting to an otorhinolaryngology/otoneurology clinic. Although it causes a substantial burden to the
individual and society there are no randomized controlled trails on prophylactic medication for this condition. Flunarizine, a calcium channel blocker has been used effectively in both migraine and vestibular conditions. This randomized control trial was undertaken in a tertiary academic referral center to evaluate the efficacy of flunarizine in patients with migrainous vertigo when compared to nonspecific vestibular treatment of betahistine and vestibular
exercises.
No other version available